Kidney Disease

The kidneys are the body's silent chemists — two fist-sized organs that filter roughly 180 liters of blood per day, regulate blood pressure, balance electrolytes, activate vitamin D, produce erythropoietin for red blood cell formation, and quietly remove the metabolic waste generated by every cell in the body. When they start to fail, they fail quietly. Chronic kidney disease (CKD) can progress through half of its course before a single symptom appears, which is why it is sometimes called the silent epidemic: an estimated 1 in 7 adults in high-income countries have some degree of CKD, and most of them do not know it. The good news is that CKD is largely a disease of two other conditions — diabetes and high blood pressure — and is therefore substantially preventable and, especially in its earlier stages, slowable with the right medical, nutritional, and lifestyle strategies.

Table of Contents

  1. What is Kidney Disease?
  2. Types of Kidney Disease
  3. Stages of Chronic Kidney Disease
  4. Common Symptoms
  5. Causes and Risk Factors
  6. Diagnosis
  7. Lab Tests to Monitor
  8. Treatment Options
  9. Natural & Nutritional Support
  10. Prevention and Management Strategies
  11. Complications of Kidney Disease
  12. References & Research
  13. Featured Videos

What is Kidney Disease?

Kidney disease refers to any condition that affects the kidneys' ability to filter waste and excess fluids from the blood to produce urine. When kidneys are damaged, waste can build up in the body, leading to a range of health problems. Kidney disease can be acute (sudden) or chronic (long-term), with chronic kidney disease (CKD) being more common and potentially leading to kidney failure if not managed properly.

Types of Kidney Disease

1. Chronic Kidney Disease (CKD)

2. Acute Kidney Injury (AKI)

3. Polycystic Kidney Disease (PKD)

4. Glomerulonephritis

Stages of Chronic Kidney Disease

CKD is classified into five stages based on the estimated glomerular filtration rate (eGFR), a measure of how much blood the kidneys filter each minute, normalized to body surface area. Staging guides both monitoring frequency and treatment intensity. An eGFR below 60 mL/min/1.73 m² sustained for more than three months is the clinical threshold for CKD.

Stage eGFR (mL/min/1.73 m²) Description Typical Management
Stage 1 ≥ 90 Normal filtration with evidence of kidney damage (e.g., protein in urine, imaging changes) Treat underlying cause; control blood pressure and blood sugar
Stage 2 60–89 Mildly reduced filtration with kidney damage Aggressive risk-factor control; annual monitoring
Stage 3a 45–59 Mild to moderate loss of function Every 6–12 months monitoring; ACE inhibitor or ARB; SGLT2 inhibitor if diabetic
Stage 3b 30–44 Moderate to severe loss of function Nephrology referral; manage anemia, bone disease, acidosis
Stage 4 15–29 Severe loss of function Prepare for renal replacement therapy; dietary protein restriction
Stage 5 < 15 Kidney failure Dialysis or kidney transplant required

A separate albuminuria axis (A1, A2, A3) modifies the stage based on urine protein loss. A patient with stage 3a eGFR but heavy proteinuria (A3) has a substantially worse prognosis than stage 3a with minimal proteinuria (A1), which is why modern CKD guidelines describe patients by both dimensions.

Common Symptoms of Kidney Disease

Symptoms may not appear until the disease is advanced. Common signs include:

Causes and Risk Factors

Diagnosis

Lab Tests to Monitor

Routine kidney-function monitoring relies on a small, focused panel of tests. Most of these are components of the Comprehensive Metabolic Panel ordered at a typical annual physical, plus a dedicated urine test.

Treatment Options

Natural & Nutritional Support

Medical therapy slows CKD; nutrition and targeted micronutrients protect the downstream systems that fail alongside the kidneys. These are adjuncts to conventional care, not substitutes, and every one of them interacts with kidney clearance — talk to your nephrologist before starting anything new, especially at stages 3b and beyond.

Prevention and Management Strategies

Complications of Kidney Disease


References & Research

Historical Background

Richard Bright, a physician at Guy's Hospital in London, first described the connection between kidney disease and protein in the urine in 1827, and chronic kidney disease was long known as "Bright's disease." The development of hemodialysis by Willem Kolff in 1943 in the Netherlands and the first successful kidney transplant by Joseph Murray in 1954 (for which he received the 1990 Nobel Prize) were transformative milestones in nephrology.

Key Research Papers

  1. Levey AS, Coresh J. Chronic kidney disease. The Lancet. 2012;379(9811):165-180.
  2. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine. 2009;150(9):604-612.
  3. Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. The Lancet. 2013;382(9888):260-272.
  4. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL trial). New England Journal of Medicine. 2001;345(12):861-869.
  5. Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes (IDNT trial). New England Journal of Medicine. 2001;345(12):851-860.
  6. Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy (CREDENCE trial). New England Journal of Medicine. 2019;380(24):2295-2306.
  7. Heerspink HJL, Stefansson BV, Correa-Rotter R, et al. Dapagliflozin in patients with chronic kidney disease (DAPA-CKD trial). New England Journal of Medicine. 2020;383(15):1436-1446.
  8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases. 2002;39(2 Suppl 1):S1-266.
  9. KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013;3(1):1-150.
  10. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017. The Lancet. 2020;395(10225):709-733.
  11. Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes (FIDELIO-DKD trial). New England Journal of Medicine. 2020;383(23):2219-2229.
  12. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New England Journal of Medicine. 2004;351(13):1296-1305.

↑ Back to Table of Contents


Research Papers

Explore current literature on chronic kidney disease via PubMed topic searches. These links open live PubMed searches for the listed keywords — results update as new studies are indexed.

↑ Back to Table of Contents

Connections

↑ Back to Table of Contents

Video Thumbnail

Chronic kidney disease: Signs, Symptoms, Treatment | Max Hospital

Video Thumbnail

Chronic kidney disease: What are the treatments?

Video Thumbnail

What causes chronic kidney disease?

Video Thumbnail

Kidney disease: what are the early signs and how is it treated?

Video Thumbnail

10 Signs of Early Kidney Disease & Kidney Labs You Need

Video Thumbnail

Doctor explains Diabetic Kidney Disease | Causes, symptoms, treatment and prevention

Video Thumbnail

Dr. Sonny Viloria discusses the causes, symptoms, and stages of chronic kidney disease | Salamat Dok

Video Thumbnail

Recognizing the Signs of Kidney Disease: What You Need to Know

Video Thumbnail

Chronic Kidney Disease (CKD): Medical-Surgical - Renal System | @LevelUpRN